Binodenoson
- Generic Name
- Binodenoson
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H25N7O4
- CAS Number
- 144348-08-3
- Unique Ingredient Identifier
- LJA4M1L5LG
- Background
Binodenoson is a pharmacologic stress agent specific to the only adenosine receptor necessary for increased cardiac blood flow, the A receptor. This specificity allows Binodenoson to deliver - in a single injection - a more effective dose of medication with fewer side effects than current treatments, which typically require a 15-20 minute infusion.
- Indication
For cardiac pharmacologic stress SPECT imaging, which is used to diagnose coronary artery disease.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 419
- Registration Number
- NCT00944294
Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 578
- Registration Number
- NCT00944970
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath